Skip to content

Fleroxacin

ANTIINFECTIVES FOR SYSTEMIC USE

Also known as: flerofloxacin, megalocin, megalone, quinodis

YEAR INTRODUCED approvedATC J01MA08

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Fleroxacin is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1992. DrugCentral lists 1 molecular target, including gyrA.

  • Molecular targets: gyrA (1 listed in DrugCentral).
  • ATC code: J01MA08 (Fluoroquinolones).
  • Molecular formula: C17H18F3N3O3; molecular weight 369.34 g/mol.

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
DNA gyrase subunit AgyrAunknownIC50 4.79

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1992-01-01YEAR INTRODUCED——

ATC classification

ATC codeTherapeutic hierarchy
J01MA08ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › QUINOLONE ANTIBACTERIALS › Fluoroquinolones

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Fleroxacin is on its molecule page.

Molecular formulaC17H18F3N3O3
Molecular weight369.34 g/mol
CAS number79660-72-3
InChIKeyXBJBPGROQZJDOJ-UHFFFAOYSA-N
PubChem CID3357
CN1CCN(CC1)C1=C(F)C=C2C(=O)C(=CN(CCF)C2=C1F)C(O)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Fleroxacin work?

Its molecular targets in DrugCentral include gyrA.

When was Fleroxacin first approved?

Fleroxacin was first approved by the YEAR INTRODUCED in 1992.

What is the chemical formula of Fleroxacin?

Fleroxacin has the molecular formula C17H18F3N3O3 and a molecular weight of 369.34 g/mol.

Browse: all drugs starting with F · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1992-01-01
AgencyYEAR INTRODUCED
Targets1
Indications0
FormulaC17H18F3N3O3
DrugCentral ID1177
Interactive profile